Neuroprognostication after cardiac arrest: time-anchored reassessment and uncertainty around zero false positives

• by Li-Xia Xu

• August 21, 2026

FDA approves tau PET imaging agent

The F18-labeled agent is indicated for brain PET imaging to identify tau neurofibrillary tangle pathology.

• by Kathryn Wighton

• August 14, 2026

• 2 min

Correction: CTE-type tau filaments in Alzheimer’s disease with co-morbid LATE-NC

• by Jaimin K. Rana, Emile S. Pinarbasi, Martin G. Fernandez, Vikas Navratna, Kyle S. Conway, Andrew P. Lieberman, Sami J. Barmada, Shyamal Mosalaganti

• August 20, 2026

Brain organoid maturation is driven by a lifelike developmental clock

• August 19, 2026